Amarin will receive an up front, pricing, and reimbursement & sales milestones based on net sales of the product & will be responsible for supplying the finished product to Lotus at a pre-defined supply price
Lotus to get an exclusive right to distribution and commercial promotion for Vazkepa in South Korea and 9 countries in ASEAN: Brunei, Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam
The collaboration uses Lotus’ commercial and marketing expertise to bring novel and transformative treatments to patients & broadens the reach of Vazkepa to additional ten countries. Vazkepa capsules were approved & commercialized in a no. of global markets, incl. the US & EU markets
Ref: Amarin | Image: Amarin
Related News:- Amarin Reports (REDUCE-IT) Study Results of Vascepa/Vazkepa (icosapent ethyl) for Acute Coronary Syndrome Event
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
